Effects of 3-aminobenzamide on expressions of poly(ADP ribose) polymerase and apoptosis inducing factor in cardiomyocytes of rats with acute myocardial infarction

Chinese Medical Journal

Volumn 122, Issue 11, 2009, Pages 1322-1327

  Zhao, Yu Juan ^a   Wang, Jian Hua ^a   Fu, Bing ^a   Ma, Mu Xin ^a   Li, Bao Xin ^a   Huang, Qi ^a   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

3 aminobenzamide; Acute myocardial infarction; Apoptosis; Apoptosis inducing factor; DNA repair; Poly(ADP ribose) polymerase

Indexed keywords

3 AMINOBENZAMIDE; APOPTOSIS INDUCING FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS INDUCING FACTOR; BENZAMIDES; BLOTTING, WESTERN; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, WISTAR;

EID: 68249139754     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.11.016     Document Type: Article

References (29)

1. Nguewa PA, Fuertes MA, Valladares B, Alonso C, Pérez JM. Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol 2005; 88: 143-172.
2. Petermann E, Keil C, Oei SL. Importance of poly(ADP-ribose) polymerases in the regulation of DNA-dependent processes. Cell Mol Life Sci 2005; 62: 731-738.
3. Tóth-Zsámboki E, Horváth E, Vargova K, Pankotai E, Murthy K, Zsengellér Z, et al. Activation of poly(ADP-ribose) polymerase by myocardial ischaemia and coronary reperfusion in human circulating leukocytes. Mol Med 2006; 12: 221-228.
4. Beneke S, Bürkle A. Poly(ADP-ribosyl)ation, PARP, and aging. Sci Aging Knowledge Environ 2004; 2004: re9.
5. Chiarugi A. Poly (ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited. Trends Pharmacol Sci 2002; 23: 122-129.
6. Koh DW, Dawson TM, Dawson VL. Poly (ADP-ribosyl)ation regulation of life and death in the nervous system. Cell Mol Life Sci 2005; 62: 760-768.
7. Erdelyi K, Bakondi E, Gergely P, Szabo C, Virag L. Pathophysiologic role of oxidative stressinduced poly (ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. Cell Mol Life Sci 2005; 62: 751-759.
8. Song ZF, Ji XP, Li XX, Wang SJ, Wang SH. Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK mediated AIF translocation. J Cell Mol Med 2008; 12: 1220-1228.
9. Ruchalski K, Mao H, Singh SK, Wang Y, Mosser DD, Li F, et al. HSP72 inhibits apoptosis inducing factor release in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol 2003; 285: C1483-C1493.
10. Tentori L, Portarena I, Graziani G. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 2002; 2: 73-85.
11. Schreiber V, Hunting D, Trucco C, Gowans B, Grunwald D, De Murcia G, et al. A dominant-negative mutant of human poly (ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage. Proc Natl Acad Sci U S A 1995; 92: 4753-4757.
12. Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res 2005; 52: 72-82.
13. Cuzzocrea S, Wang ZQ. Role of poly (ADP-ribose) glycohydrolase (PARG) in shock, ischaemia and reperfusion. Pharmacol Res 2005; 52: 100-108.
14. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis inducing factor. Science 2002; 297: 259-263.
15. Liaudet L, Szabo E, Timashpolsky L, Virag L, Cziraki A, Szabo C. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br J Pharmacol 2001; 133: 1424-1430.
16. Faro R, Toyoda Y, McCully JD, Jagtap P, Szabo E, Virag L, et al. Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor. Ann Thorac Surg 2002; 73: 575-581.
17. Hauser B, Groger M, Ehrmann U, Albicini M, Bruckner UB, Schelzig H, et al. The parp-1 inhibitor ino-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping induced ischaemia/ reperfusion. Shock 2006; 25: 633-640.
18. Strosznajder R, Gajkowska B. Effect of 3-aminobenzamide on Bcl-2, Bax and AIF localization in hippocampal neurons altered by ischaemia-reperfusion injury: the immunocytochemical study. Acta Neurobiol Exp (Wars) 2006; 66: 15-22.
19. Heeres JT, Hergenrother PJ. Poly (ADP-ribose) makes a date with death. Curr Opin Chem Biol 2007; 11: 644-653.
20. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, et al. Apoptosis inducing factor mediates poly (ADP-ribose) (PAR) polymer induced cell death. Proc Natl Acad Sci U S A 2006; 103: 18314-18319.
21. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
22. Li YH, Zhuo YH, Lu L, Chen LY, Huang XH, Zhang JL, et al. Caspase-dependent retinal ganglion cell apoptosis in the rat model of acute diabetes. Chin Med J 2008; 121: 2566-2571.
23. Wu ZQ, Zhang R, Chao C, Zhang JF, Zhang YQ. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. Chin Med J 2007; 120: 2112-2118.
24. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-de Murcia J, et al. Sequential activation of poly (ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis inducing factor mediated programmed necrosis. Mol Cell Biol 2007; 27: 4844-4862.
25. van Empel VP, Bertrand AT, Van Der Nagel R, Kostin S, Doevendans PA, Crijns HJ, et al. Downregulation of apoptosis inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload induced decompensation. Circ Res 2005; 96: e92-e101.
26. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, et al. Apoptosis inducing factor mediates poly (ADP-ribose) (PAR) polymer induced cell death. Proc Natl Acad Sci U S A 2006; 103: 18314-18319.
27. Molnár A, Tóth A, Bagi Z, Papp Z, Edes I, Vaszily M, et al. Activation of the poly(ADP-ribose) polymerase pathway in human heart failure. Mol Med 2006; 12: 143-152.
28. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly (ADP-ribose) polymerase-1-depend-ent cell death by apoptosis inducing factor. Science 2002; 297: 259-263.
29. Chen M, Zsengeller Z, Xiao CY, Szabo C. Mitochondrial-to-nuclear translocation of apoptosis inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. Cardiovasc Res 2004; 63: 682-688.